Cytek Biosciences(CTKB)
FREMONT, CABiotechnology
Focus: Cytek Biosciences is a publicly traded biotechnology company specializing in flow cytometry instruments and systems for research and diagnostics. The company operates as a mid-cap biotech with ~$193M in FY 2025 revenue and a focus on metabolic disease applications.
Profile data last refreshed 16h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Open Jobs
20+2 this month
Stable — net +2 jobs in 30d
15 added, 13 removed. Backfill posture.
Should You Work at Cytek Biosciences?
AI assessmentCytek offers growth potential and public-company stability, but recent margin deterioration and analyst skepticism make it a moderate-risk choice for risk-averse candidates.
Why Work Here
- Public company with established $193M revenue base and 18% YoY growth (FY 2024→2025), providing stability relative to pre-revenue biotech.
- Active hiring across Commercial (5 roles), Engineering (4 roles), and other functions indicates expansion phase despite near-term profitability headwinds.
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$193M
Help build intelligence for Cytek Biosciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.